GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nyrada Inc (ASX:NYR) » Definitions » Total Debt per Share

Nyrada (ASX:NYR) Total Debt per Share : A$0.00 (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Nyrada Total Debt per Share?

A$0.00 (As of Dec. 2023)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Nyrada's Total Debt Per Share for the quarter that ended in Dec. 2023 was A$0.00.


Nyrada Total Debt per Share Historical Data

The historical data trend for Nyrada's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nyrada Total Debt per Share Chart

Nyrada Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
Total Debt per Share
- - - - -

Nyrada Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Debt per Share Get a 7-Day Free Trial - - - - -

Nyrada Total Debt per Share Calculation

Nyrada's Total Debt Per Share for the fiscal year that ended in Jun. 2023 is calculated as:

Nyrada's Total Debt Per Share for the quarter that ended in Dec. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nyrada Total Debt per Share Related Terms

Thank you for viewing the detailed overview of Nyrada's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Nyrada (ASX:NYR) Business Description

Traded in Other Exchanges
N/A
Address
828 Pacific Highway, Suite 2, Level 3, Gordon, NSW, AUS, 2072
Nyrada Inc is a preclinical-stage, drug discovery, and development company, specializing in novel small-molecule drugs to treat cardiovascular and neurological diseases. The company's two programs center on cholesterol-lowering and brain injury, each targeting market sectors of notable size and unmet clinical needs. The programs are focused on developing an oral, small molecule cholesterol-lowering drug, and a drug to treat secondary brain damage following a stroke or traumatic brain injury.

Nyrada (ASX:NYR) Headlines

No Headlines